IRCT20190114042358N3CompletedPhase 2
Dexmedetomidine sedation in awake caudal block for lower abdominal surgeries in neonates
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 day to 30 days (—)
- Sex
- All
Inclusion Criteria
- •Infant Weighing less than 4 Kg
- •Surgery of the lower abdomen
- •ASA Class 1 and2
Exclusion Criteria
- •Patients with congenital neurological disease and seizures
- •Caudal injection site infection
- •Sensitivity to topical anesthetics
- •Bradycardia(HR<120)
- •Any kind of heart block
- •Congenital cyanotic heart diseases
Investigators
Similar Trials
Terminated
Phase 3
Dexmedetomidine Sedation for Awake Fibreoptic BronchoscopySafety and Feasibility of Dexmedetomidine Sedation for Awake Fibreoptic BronchoscopyAnaesthesiology - AnaestheticsACTRN12608000304336Keat Lee100
Active, not recruiting
Not Applicable
Dexmedetomidine during the implantation of a neurostimulator in awake patients.Awake implantation of a neuromodulative system.EUCTR2014-001587-35-NLErasmus Medical Centre, Department of Anesthesiology
Completed
Phase 2
Dexmedetomidine in awake implantation of neuromodulative systems.Awake implantation of a neuromodulative system.10041543NL-OMON41067Erasmus MC, Universitair Medisch Centrum Rotterdam10
Withdrawn
Not Applicable
The effect of sedation with dexmedetomidine on the incidence of delirium after spinal anesthesia in elderly patients with hip surgeryKCT0003133Yonsei University, Wonju Severance Christian Hospital110
Not yet recruiting
Phase 2
Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia after Knee SurgeriesOrthopaedicsAnaesthesiaPACTR202304775359949Faculty of Medicine Kafr Elsheikh University70